Asymmetric Dimethyl l-Arginine (ADMA) is a critical regulator of myocardial reperfusion injury
Myocardial Reperfusion Injury
Nitric Oxide Synthase
Accumulation of tissue ADMA by impairment of DDAH was found to be a significant determinant of reperfusion injury. Our results indicate that ADMA could be a potential new target for the treatment of myocardial ischemia/reperfusion injury.